Importantly, elucidating the cytogenetic and molecular mechanisms that give rise to the evolution of BRAF-mutant myeloid neoplasms may enable the development of novel treatment approaches for patients [13]. The gene discussed is BRAF; the disease is myeloid neoplasm.